Everett Cunningham
Chief Commercial Officer
Other
CEO
Board Member
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Illumina, Inc. (ILMN) | Former Chief Commercial Officer | $650,000 | $4,087,101 |
| 2024 | EXACT SCIENCES CORP (EXAS) | Former Executive Vice President and Former Chief Commercial Officer | $315,503 | $4,141,654 |
| 2024 | Illumina, Inc. (ILMN) | Chief Commercial Officer | $350,000 | $10,073,818 |
| 2023 | EXACT SCIENCES CORP (EXAS) | Executive Vice President and Chief Commercial Officer | $703,000 | $4,546,966 |
| 2022 | EXACT SCIENCES CORP (EXAS) | Executive Vice President and Chief Commercial Officer | $675,500 | $5,176,570 |
| 2021 | EXACT SCIENCES CORP (EXAS) | Executive Vice President and Chief Commercial Officer | $137,500 | $9,872,553 |
Executive changes
Earnings-call appearances
-
CG 46th Annual Growth Conference2026-08-12
Quanterix Corp (QTRX)
-
Quanterix Corporation Q2 2026 Earnings Call2026-08-10
Quanterix Corp (QTRX)
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09
Quanterix Corp (QTRX)
-
Quanterix Corp Q1 FY2026 Earnings Call2026-05-06
Quanterix Corp (QTRX)
-
Quanterix Corp Q4 FY2025 Earnings Call2026-03-02
Quanterix Corp (QTRX)
-
EXACT SCIENCES CORP Q1 FY2024 Earnings Call2024-05-08
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q4 FY2023 Earnings Call2024-02-21
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q3 FY2023 Earnings Call2023-11-01
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q2 FY2023 Earnings Call2023-08-01
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q1 FY2023 Earnings Call2023-05-09
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q4 FY2022 Earnings Call2023-01-09
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q3 FY2022 Earnings Call2022-11-03
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q2 FY2022 Earnings Call2022-08-02
EXACT SCIENCES CORP (EXAS)
-
EXACT SCIENCES CORP Q1 FY2022 Earnings Call2022-04-26
EXACT SCIENCES CORP (EXAS)